Paraptosis: a non-classical paradigm of cell death for cancer therapy

Area of Science:

• Cell Biology
• Molecular Oncology
• Biochemistry

Background:

• Cancer cells exhibit sustained proliferation, necessitating cell death induction for effective therapy.
• Paraptosis, a distinct form of programmed cell death, involves endoplasmic reticulum (ER) and mitochondrial swelling, and cytoplasmic vacuolization.
• While paraptosis is less understood, its induction by chemical compounds in cancer cells suggests therapeutic potential.

Purpose of the Study:

• To review current knowledge on chemical compound-induced paraptosis.
• To elucidate the molecular mechanisms and cellular responses involved in paraptosis.
• To identify challenges and future research directions for developing paraptosis-based cancer therapies.

Main Methods:

• Literature review summarizing existing research on chemical compound-induced paraptosis.
• Analysis of the roles of the endoplasmic reticulum (ER) and mitochondria in paraptosis.
• Discussion of key molecular events including protein degradation, sulfhydryl homeostasis, calcium overload, and reactive oxygen species generation.

Main Results:

• Chemical compounds can trigger paraptosis, a cell death pathway characterized by ER and mitochondrial swelling.
• Key mechanisms involve impaired protein degradation, disrupted sulfhydryl balance, mitochondrial calcium overload, and increased reactive oxygen species.
• The ER and mitochondria are central organelles responding to chemical inducers of paraptosis.

Conclusions:

• Paraptosis represents a promising, yet underexplored, avenue for cancer therapy.
• Understanding the molecular triggers and cellular consequences of paraptosis can guide the development of novel anti-cancer drugs.
• Targeting paraptosis may offer a new therapeutic paradigm for managing cancer.